This report outlines best practices in toxicology to support safer and more efficient drug development, covering toxicity assessment approaches, regulatory considerations, and the use of data and emerging methods to improve preclinical decision-making.

Key takeaways:

Early, data-driven toxicity assessment improves candidate selection and reduces late-stage failure
Integration of in silico, in vitro, and in vivo methods enhances predictive accuracy
Alignment with evolving regulatory expectations is critical
Leveraging real-world data and advanced analytics supports better risk evaluation
Cross-functional collaboration accelerates safer development decisions

Download the Full Toxicology Report

Job function *

Please check this box to receive electronic communications from Clarivate about services, events, resources and offers you may find of interest. Clarivate will use your personal data to provide you with targeted communications, including via third-party sites, which may involve providing your (hashed) data to our partners. You acknowledge that your data may be processed in countries outside your residence, such as the United States. You can withdraw your consent anytime, including by unsubscribing from our mailing list. Further details can be found in our Privacy Notice.

By submitting this form, I understand my information will be processed in accordance with the Privacy Notice.